IDEXX Laboratories, Inc.
IDXX
$579.85
$2.730.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.62% | -6.59% | 21.14% | 12.27% | -7.17% |
| Total Depreciation and Amortization | 5.72% | 2.39% | 5.02% | 1.06% | -1.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -53.29% | 459.80% | -9.45% | 4.80% | 99.61% |
| Change in Net Operating Assets | 185.11% | 87.82% | -170.00% | -594.76% | 84.77% |
| Cash from Operations | -11.58% | 116.61% | -21.94% | -9.18% | 19.06% |
| Capital Expenditure | 5.40% | 8.76% | -13.57% | -2.64% | -4.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 109.48% | -3,002.32% | 13.94% | 103.93% | -2,651.33% |
| Cash from Investing | 37.31% | -33.43% | -13.57% | 25.68% | -45.58% |
| Total Debt Issued | 255.65% | -147.78% | 273.38% | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | 100.00% |
| Issuance of Common Stock | -64.94% | 194.11% | 140.93% | -45.73% | 165.31% |
| Repurchase of Common Stock | 1.02% | 29.14% | 16.69% | -65.43% | -11.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.53% | -89.16% | 49.86% | -41.90% | 20.00% |
| Foreign Exchange rate Adjustments | 95.91% | -104.15% | 707.65% | 76.18% | -283.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.48% | 6,882.69% | 100.50% | -510.19% | 78.09% |